Addressing Unresolved Symptoms Of Major Depressive Disorder (MDD): The Importance Of Norepinephrine, Serotonin, & Dopamine Modulation

Join the PsychU community for this exciting webinar featuring experts in psychiatry, Joseph Goldberg and Vladimir Maletic, as they describe aspects of pathophysiology in major depressive disorder.  An emphasis will be placed on the role of several monoamine neurotransmitter systems including norepinephrine, serotonin, and dopamine.  Drs. Goldberg and Maletic will highlight the burden of disease in depression and discuss current guideline recommendations on MDD treatments, including considerations for augmentation strategies.   Guided by moderator, Rachel Self, they will discuss the current psychiatry treatment landscape and provide context around recent publications raising questions regarding depression pathophysiology and the monoamine model.

Join us for an exciting and informative dialogue on the pathophysiology of depression and treatment recommendations for those with unresolved symptoms!

Vladimir Maletic, MD

Serves as Clinical Professor, Psychiatry/Behavioral Science, University of South Carolina School of Medicine Greenville, SC

More

Vladimir Maletic, MD serves as Clinical Professor, Psychiatry/Behavioral Science, School of Medicine Greenville, SC and has been rated as Best Doctors of the America Registry and Psychiatrist of the year.  Dr. Maletic received the Upjohn Achievement Award and Student Council teaching award and faculty award for teaching achievement.  He also has received the Medical School Award for Academic Achievement.

Joseph Goldberg, MD

Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai

More

Joseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. He attended college at the University of Chicago, graduate school in neuroscience at the University of Illinois, and medical school at Northwestern University. He completed his residency and chief residency in psychiatry, and fellowship in psychopharmacology, at the Payne Whitney Clinic, New York Presbyterian Hospital, where he later served on the faculty and was site Principal Investigator at Weill-Cornell Medical Center for the NIMH STEP-BD program. He has published over 200 peer-reviewed papers on topics related mainly to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology, most recently “Managing the Side Effects of Psychotropic Medications, 2nd edition” published in 2019 by American Psychiatric Publishing, and the forthcoming “Practical Psychopharmacology” by Cambridge University Press. He serves on the Board of Directors for the American Society of Clinical Psychopharmacology and is on the editorial boards for a number of peer-reviewed journals. His research has been awarded funding from NARSAD, NIMH, the Stanley Foundation, and the American Foundation for Suicide Prevention. Dr. Goldberg is a Distinguished Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly’s “America’s Top Doctors.”

Rachel Self, PhD, MS (OPDC)

Medical Science Director, Neuroscience Field Medical Affairs

More

Rachel Self, PhD, MS is a Medical Science Director for Otsuka’s Neuroscience Field Medical Affairs, neuroscientist, & wellness advocate.

Joseph Goldberg & Vladimir Maletic are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Rachel Self is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)